Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.
Ziconotide is a conopeptide intrathecal (IT) analgesic which is approved by the US Food and Drug Administration (FDA) for the management of severe chronic pain. It is a synthetic equivalent of a naturally occurring conopeptide found in the venom of the fish-eating marine cone snail and provides analgesia via binding to N-type voltage-sensitive calcium channels in the spinal cord. As ziconotide is a peptide, it is expected to be completely degraded by endopeptidases and exopeptidases (Phase I hydrolytic enzymes) widely located throughout the body, and not by other Phase I biotransformation processes (including the cytochrome P450 system) or by Phase II conjugation reactions. Thus, IT administration, low plasma ziconotide concentrations, and metabolism by ubiquitous peptidases make metabolic interactions of other drugs with ziconotide unlikely. Side effects of ziconotide which tend to occur more commonly at higher doses may include: nausea, vomiting, confusion, postural hypotension, abnormal gait, urinary retention, nystagmus/amblyopia, drowsiness/somnolence (reduced level of consciousness), dizziness or lightheadedness, weakness, visual problems (eg, double vision), elevation of serum creatine kinase, or vestibular side effects. Initially, when ziconotide was first administered to human subjects, titration schedules were overly aggressive and led to an abundance of adverse effects. Subsequently, clinicians have gained appreciation for ziconotide's relatively narrow therapeutic window. With appropriate usage multiple studies have shown ziconotide to be a safe and effective intrathecal analgesic alone or in combination with other intrathecal analgesics.
Smith
Howard S
HS
Albany Medical College, Department of Anesthesiology, Albany, New York, USA.
Deer
Timothy R
TR
Anesth Analg. 2008 Feb;106(2):628-37, table of contents
18227325
Annu Rev Biochem. 1994;63:823-67
7979255
J Theor Biol. 2006 Nov 21;243(2):252-60
16890961
J Pain Symptom Manage. 2004 Jun;27(6):540-63
15165652
Rev Neurol. 2007 Dec 1-15;45(11):665-9
18050098
Pain Med. 2008 Apr;9(3):271-81
18366507
Annu Rev Pharmacol Toxicol. 1995;35:707-34
7598513
Eur J Phys Rehabil Med. 2009 Mar;45(1):61-7
19156022
J Pain Symptom Manage. 2004 Sep;28(3):268-72
15336339
CNS Drugs. 2006;20(4):331-8; discussion 339-41
16599651
Pain. 2000 Feb;84(2-3):271-81
10666532
Mol Cell Neurosci. 1994 Jun;5(3):219-28
8087420
Neuromodulation. 2005 Jul;8(3):153-4
22151483
J Neurosci. 1987 Aug;7(8):2390-6
3112325
J Biol Chem. 2006 Oct 20;281(42):31173-7
16905531
Neuromodulation. 2007 Oct;10 Suppl 1:6-11
22150946
Expert Rev Neurother. 2006 Oct;6(10):1423-8
17078783
J Pain Symptom Manage. 2009 Mar;37(3):363-72
18715748
Peptides. 2000 Apr;21(4):491-501
10822104
Curr Med Chem. 2004 Dec;11(23):3029-40
15578997
Neuromodulation. 2007 Oct;10 Suppl 1:12-7
22150947
Naunyn Schmiedebergs Arch Pharmacol. 2002 Sep;366(3):270-5
12172710
Biochemistry. 1987 Apr 21;26(8):2086-90
2441741
Anesthesiology. 2003 Jul;99(1):174-87
12826858
Brain Res. 1994 Aug 8;653(1-2):258-66
7982059
Drug Saf. 2007;30(2):93-105
17253876
J Biol Chem. 2007 Dec 21;282(51):36905-13
17962189
JAMA. 2004 Jan 7;291(1):63-70
14709577
Neuromodulation. 2005 Oct;8(4):257-63
22151554
J Clin Pharmacol. 2003 Jun;43(6):624-36
12817525
Neuromodulation. 2007 Oct;10(4):300-28
22150890
Pain Med. 2008 Apr;9(3):282-90
18366508
Physiol Rev. 2004 Jan;84(1):41-68
14715910
Neuroreport. 1994 May 9;5(9):1121-4
8080970
Biochem Biophys Res Commun. 1995 Jan 17;206(2):449-54
7826361
Toxicon. 1998 Nov;36(11):1651-8
9792182
Biochem Biophys Res Commun. 2007 Mar 9;354(2):548-51
17239817
Int J Pept Protein Res. 1995 Sep-Oct;46(3-4):320-5
8537186
J Pain Symptom Manage. 2006 May;31(5):393-406
16716870
Biochemistry. 2000 Apr 11;39(14):3908-19
10747778
Neuromodulation. 2007 Oct;10 Suppl 1:1-5
22150945
Neuromodulation. 2006 Apr;9(2):75-86
22151630
Science. 1990 Jul 20;249(4966):257-63
2165278
Brain Nerve. 2008 May;60(5):509-17
18516973
Biochemistry. 1998 Jul 7;37(27):9851-61
9657699
Biochemistry. 2009 Feb 17;48(6):1210-9
19170536
Pain. 1995 Jan;60(1):83-90
7715945
Pain. 2000 Feb;84(2-3):151-8
10666519
J Pain Symptom Manage. 2000 Aug;20(2):S37-43
10989256
Pharmacotherapy. 2006 Mar;26(3):395-402
16503720
Pain Physician. 2008 Mar;11(2 Suppl):S89-S104
18443642
Int J Toxicol. 2007 Sep-Oct;26(5):411-21
17963128
J Pharmacol Exp Ther. 1996 Dec;279(3):1243-9
8968347
J Pain Symptom Manage. 2006 Dec;32(6):509-11
17157748